BOCA RATON, Fla., July 21, 2026 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the second quarter ended June 30, 2026, after the market closes on Tuesday, July 28, 2026.
Management will host a conference call and audio webcast on Tuesday, July 28, 2026, at 4:30 p.m. ET to discuss the Company’s financial results.
| Event: | Second Quarter 2026 Financial Results Conference Call |
| Date: | Tuesday, July 28, 2026 |
| Time: | 4:30 p.m. Eastern Time |
| Live Call: | 1-877-423-9813 (U.S. & Canada Toll-Free) |
| Conference ID | 13761211 |
| Webcast: | Register |
For interested individuals unable to join the conference call, a webcast of the call will be available until August 28, 2026 and can be accessed via webcast on Jushi’s Investor Relations website.
About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, Instagram, Facebook, X, and LinkedIn.
For further information, please contact:
Jushi Investor Relations
Trent Woloveck
Co-Chief Strategy Director
614-271-4349
trent@jushico.com
investors@jushico.com
The article outlines how gentle chiropractic techniques support spinal alignment and movement in children and…
Collaboration creates a path to combine Signant's market-leading eCOA and digital endpoint capabilities with Lothar…
Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration,…
US-based research peptide supplier broadens third-party analytical testing and per-batch Certificate of Analysis documentation across…
Montreal, Quebec--(Newsfile Corp. - September 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE:…
Accreditation affirms MMRO's commitment to responsible AI governance, human oversight, and clinical integrity.NOVI, Mich., Sept.…